How to Get a GLP-1 Prescription: Qualifying, Doctors & Telehealth

How do I qualify for a GLP-1 if I'm not diabetic?

This is the single most common question people ask, and the answer is reassuring: you do not need to have diabetes to be a candidate for a GLP-1. The newer GLP-1 medications most people are searching for — Wegovy and Zepbound — are specifically approved for chronic weight management, which is a completely separate FDA indication from diabetes.

The confusion comes from history. The first GLP-1 drugs were developed for type 2 diabetes (think Ozempic and Mounjaro), so many people assume a diabetes diagnosis is the only way in. But once researchers saw how powerfully these drugs reduce appetite, manufacturers ran separate trials and earned separate approvals for obesity. Today, Wegovy (semaglutide) and Zepbound (tirzepatide) are approved for adults with obesity, or who are overweight with a related health condition — no diabetes required.

In practice, qualifying through the weight pathway means a clinician confirms you meet the BMI criteria below, reviews your health history to make sure a GLP-1 is safe for you, and documents a weight-related diagnosis. If you'd like the broader background on what these drugs actually are first, our explainer on what GLP-1 is is a good starting point.

What BMI do I need for Wegovy or Zepbound?

The eligibility thresholds for chronic weight management are set by the FDA and are consistent across the major weight-loss GLP-1 products. You generally qualify if you have:

• A BMI of 30 or higher (the clinical definition of obesity), or
• A BMI of 27 or higher (overweight) plus at least one weight-related condition — such as high blood pressure, type 2 diabetes, high cholesterol (dyslipidemia), or obstructive sleep apnea.

Some of these medications are also approved for adolescents aged 12 and older who meet specific weight criteria, though that's a decision made carefully with a pediatric clinician. BMI is a screening tool, not the whole story — a clinician will also consider your body composition, where you carry weight, and your overall health picture rather than treating the number as an automatic yes or no.

Thresholds reflect FDA-approved labeling for chronic weight management; your clinician makes the final determination. People with type 2 diabetes may qualify under a separate diabetes indication regardless of BMI.

What lab tests are usually done first?

Before prescribing a GLP-1, most clinicians order a round of baseline blood work and take a careful history. This isn't bureaucratic box-ticking — it establishes a starting point, screens for conditions that change the risk-benefit calculation, and helps tailor the right medication. What you can typically expect:

• A1c or fasting blood glucose — to check for prediabetes or undiagnosed diabetes, which can affect drug choice and dosing.
• A kidney and metabolic panel (often a comprehensive metabolic panel) — to confirm your kidneys and liver are healthy before starting.
• A lipid panel — your cholesterol and triglycerides, which double as a weight-related condition and a baseline to track.

Beyond labs, your clinician will review your personal and family history of medullary thyroid carcinoma (MTC) or the genetic syndrome MEN 2, because GLP-1 drugs carry a boxed warning related to thyroid tumors seen in animal studies. They'll also confirm pregnancy status, since these drugs aren't used in pregnancy, and ask about any history of pancreatitis or gallbladder disease. None of this guarantees an outcome — it's how a responsible prescriber decides whether a GLP-1 is safe for you.

Telehealth vs. your PCP vs. a specialist: where should I go?

There's no single "right" door. The best route depends on your insurance, the complexity of your health, and how much hand-holding you want. Here's an honest look at the three main paths.

A reasonable default for many people is to start with their PCP — they already know your history and can coordinate labs and insurance. If your case is more complex, you've tried medications before, or you want someone who lives and breathes this, an obesity-medicine specialist or endocrinologist is worth the wait. Telehealth shines when you value convenience and don't mind paying cash, but it tends to offer less continuity than a doctor who sees you in person over time.

Are telehealth providers like Ro, Hims, Henry Meds and Mochi legitimate?

Mostly, yes — with caveats worth understanding. Established telehealth companies such as Ro, Hims, Henry Meds and Mochi are legitimate businesses that require a real medical intake reviewed by a licensed prescriber before any medication is dispensed. They are not pill-mills selling drugs over the counter; the good ones collect your history, may require labs, and connect you to a clinician who makes the prescribing decision.

That said, the telehealth GLP-1 space has attracted some bad actors, so apply a few simple checks before you hand over a credit card:

• There must be a real medical evaluation. Be cautious of any service willing to sell you a product without a proper intake and a prescriber reviewing it.
• Verify a US-licensed prescriber. A legitimate service uses clinicians licensed in your state.
• Verify a licensed US pharmacy. Your medication should come from a properly licensed pharmacy — not an anonymous overseas shipper.
• Understand what you're buying. Some services offer branded Wegovy or Zepbound; others offer compounded semaglutide or tirzepatide, which is a different thing with its own considerations. We unpack the pricing and the compounded-vs-branded question in the cost and insurance guide.

Can I get a GLP-1 if I only need to lose ~20 pounds?

This one comes up constantly, and the honest answer is: it depends on where 20 pounds puts your BMI. The weight-management approvals are tied to BMI thresholds, not to a goal weight or how you feel about your body. If you're 20 pounds above your ideal weight but your BMI is comfortably under 27, you likely won't meet the FDA-approved criteria for chronic weight management.

If, on the other hand, losing 20 pounds is what stands between you and a BMI of 30 — or 27 with a weight-related condition — you may well qualify. The math is individual. Two people who both "want to lose 20 pounds" can land on opposite sides of the threshold depending on their height and starting weight.

It's also worth remembering that BMI thresholds exist because these are powerful prescription drugs with real side effects and costs, intended to treat obesity as a medical condition rather than to shave off vanity pounds. Whether a GLP-1 makes sense for a smaller amount of weight is a genuinely individual decision to make with a licensed clinician — not something to chase through an unregulated seller because you didn't meet the criteria. For realistic expectations on results, see our weight-loss guide.

How do I talk to my doctor about it?

Bringing up weight and medication can feel awkward, but a prepared, matter-of-fact conversation almost always goes better than hoping the topic comes up on its own. Treat it like any other medical appointment: arrive with your evidence and your questions. Come ready with:

• Your weight history — roughly how your weight has trended over the years, and any patterns you've noticed.
• Prior attempts — the diets, programs, apps or medications you've tried and what happened. This documents that you've made genuine efforts, which clinicians and insurers care about.
• Related health conditions — high blood pressure, prediabetes, sleep apnea, joint pain or anything tied to weight, since these can establish eligibility.
• Your current medications and goals — what you're taking now and what you're realistically hoping to achieve.

Then ask directly: "Do you think a GLP-1 medication is appropriate for me, and what would the risks and monitoring look like?" Framing it as a shared decision invites your clinician to think it through with you rather than feeling put on the spot. If they're not comfortable prescribing it themselves, ask for a referral to someone who specializes in obesity medicine.

What to expect in week 1

If you and your clinician decide to move forward, the first week is deliberately gentle. GLP-1 medications are titrated — you start on a low "starter" dose that is intentionally sub-therapeutic. That starting dose usually isn't enough to produce meaningful weight loss on its own; its job is to let your body adjust and to minimize side effects before stepping up.

In that first week you may notice mild gastrointestinal effects — some nausea, a fuller feeling after smaller meals, occasional reflux, or changes in bowel habits. For most people these are manageable and ease as the body adapts. The dose is then increased gradually, typically over weeks to months, until you reach an effective maintenance level. This slow ramp is the single biggest reason people tolerate these drugs as well as they do.

Two practical notes for week one: eat slower and stop when you feel full (your fullness signal will be stronger than you're used to), and don't be alarmed that the scale isn't moving yet — that's expected at the starter dose. For the full schedule of how doses step up and how to manage early side effects, see our dosing guide and the side effects guide.

The bottom line

Getting a GLP-1 prescription isn't a mystery, and you don't need diabetes to qualify. The path is: confirm you meet the weight-management criteria (BMI ≥ 30, or ≥ 27 with a related condition), get basic labs and a history review, and work with a licensed clinician — your PCP, a specialist, or a legitimate telehealth service — to decide whether a GLP-1 is right for you. No one can promise approval, and that's a feature, not a bug: these are serious medicines that deserve a real medical decision.

From here, a sensible next step is understanding what these drugs actually cost and how insurance handles them, or comparing the specific medications so you walk into your appointment informed.

Frequently asked questions